au.\*:("European Society for Infection in Urology")
Results 1 to 25 of 44
Selection :
Prostatitis: Disorders in semen and male infertilityAndrologia. 2003, Vol 35, Num 5, issn 0303-4569, 85 p.Conference Proceedings
Male accessory gland infection: standardization of inflammatory parameters including cytokinesHOCHREITER, W. W.Andrologia. 2003, Vol 35, Num 5, pp 300-303, issn 0303-4569, 4 p.Conference Paper
Inflammatory-associated obstructions of the male reproductive tractDOHLE, G. R.Andrologia. 2003, Vol 35, Num 5, pp 321-324, issn 0303-4569, 4 p.Conference Paper
Epidemiology and demographics of prostatitisSCHAEFFER, A. J.Andrologia. 2003, Vol 35, Num 5, pp 252-257, issn 0303-4569, 6 p.Conference Paper
Antibiotic therapy: rationale and evidence for optimal drug concentrations in prostatic and seminal fluid and in prostatic tissueNABER, Kurt G; SÖRGEL, Fritz.Andrologia. 2003, Vol 35, Num 5, pp 331-335, issn 0303-4569, 5 p.Conference Paper
The limit of leucocytospermia from the microbiological viewpointPUNAB, Margus; LOIVUKENE, Krista; KERMES, Kadri et al.Andrologia. 2003, Vol 35, Num 5, pp 271-278, issn 0303-4569, 8 p.Conference Paper
Aetiology of haemospermiaPAPP, G. K; KOPA, Z; SZABO, F et al.Andrologia. 2003, Vol 35, Num 5, pp 317-320, issn 0303-4569, 4 p.Conference Paper
Chlamydial and ureaplasmal infections in patients with nonbacterial chronic prostatitisBADALYAN, R. R; FANARJYAN, S. V; AGHAJANYAN, I. G et al.Andrologia. 2003, Vol 35, Num 5, pp 263-265, issn 0303-4569, 3 p.Conference Paper
Morphological sperm alternations in different types of prostatitisMENKVELD, R; HUWE, P; LUDWIG, M et al.Andrologia. 2003, Vol 35, Num 5, pp 288-293, issn 0303-4569, 6 p.Conference Paper
Seminal oxidative stress in patients with chronic prostatitisPOTTS, J. M; PASQUALOTTO, F. F.Andrologia. 2003, Vol 35, Num 5, pp 304-308, issn 0303-4569, 5 p.Conference Paper
The 2001 Giessen Cohort Study on patients with prostatitis syndrome: an evaluation of inflammatory status and search for microorganisms 10 years after a first analysisSCHNEIDER, H; LUDWIG, M; HOSSAIN, H. M et al.Andrologia. 2003, Vol 35, Num 5, pp 258-262, issn 0303-4569, 5 p.Conference Paper
Immunological alterations in the ejaculate of chronic prostatitis patients: clues for autoimmunityJOHN, H; MAAKE, C; BARGHORN, A et al.Andrologia. 2003, Vol 35, Num 5, pp 294-299, issn 0303-4569, 6 p.Conference Paper
Urogenital infection and sperm motilityDIEMER, T; HUWE, P; LUDWIG, M et al.Andrologia. 2003, Vol 35, Num 5, pp 283-287, issn 0303-4569, 5 p.Conference Paper
Acrosome reaction in Chlamydia-positive and negative patientsJUNGWIRTH, A; STRABERGER, A; ESTERBAUER, B et al.Andrologia. 2003, Vol 35, Num 5, pp 314-316, issn 0303-4569, 3 p.Conference Paper
Seminal fluid analysis in chronic prostatitis/chronic pelvic pain syndromeKRIEGER, J. N; ROSS, S. O; DEUTSCH, L et al.Andrologia. 2003, Vol 35, Num 5, pp 266-270, issn 0303-4569, 5 p.Conference Paper
ISC disease management series - Complicated and nosocomial urinary tract infections: Part II of the International Symposium Hot Topics in Urinary Tract Infection, January 25, 2003, Budapest, HungaryNABER, Kurt G; PECHERE, Jean-Claude; LUDWIG, Endre et al.International journal of antimicrobial agents. 2004, Vol 23, issn 0924-8579, 90 p., SUP1Conference Proceedings
Chronic prostatitis and male accessory gland infection: is there an impact on male infertility (diagnosis and therapy)?EVERAERT, K; MAHMOUD, A; DEPUYDT, C et al.Andrologia. 2003, Vol 35, Num 5, pp 325-330, issn 0303-4569, 6 p.Conference Paper
Cellular and biochemical markers in semen indicating male accessory gland inflammationKRAUSE, W; BOHRING, C; GUETH, A et al.Andrologia. 2003, Vol 35, Num 5, pp 279-282, issn 0303-4569, 4 p.Conference Paper
Single-drug or combined antibacterial therapy in the treatment of patients with chronic prostatitis and Chlamydia trachomatis?SMELOV, V; GORELOV, A; SMELOVA, N et al.International journal of antimicrobial agents. 2004, Vol 23, pp S83-S87, issn 0924-8579, SUP1Conference Paper
Gatifloxacin 200 mg or 400 mg once daily is as effective as ciprofloxacin 500 mg twice daily for the treatment of patients with acute pyelonephritis or complicated urinary tract infectionsNABER, K. G; BARTNICKI, A; BISCHOFF, W et al.International journal of antimicrobial agents. 2004, Vol 23, pp S41-S53, issn 0924-8579, SUP1Conference Paper
Bacterial biofilm formation on urologic devices and heparin coating as preventive strategyTENKE, Peter; RIEDL, Claus R; JONES, Gwennan Ll et al.International journal of antimicrobial agents. 2004, Vol 23, pp S67-S74, issn 0924-8579, SUP1Conference Paper
Controversies in antibiotic prophylaxis in urologyGRABE, Magnus.International journal of antimicrobial agents. 2004, Vol 23, pp S17-S23, issn 0924-8579, SUP1Conference Paper
Azithromycin treatment follow-up: antibacterial susceptibility of Chlamydia trachomatis in patients with chronic prostatitisSMELOV, V; KRYLOVA, T; SMELOVA, N et al.International journal of antimicrobial agents. 2004, Vol 23, pp S79-S82, issn 0924-8579, SUP1Conference Paper
Urinary bactericidal activity, urinary excretion and plasma concentrations of gatifloxacin (400 mg) versus ciprofloxacin (500 mg) in healthy volunteers after a single oral doseBOY, Dieter; WELL, Michaela; KINZIG-SCHIPPERS, Martina et al.International journal of antimicrobial agents. 2004, Vol 23, pp S6-S16, issn 0924-8579, SUP1Conference Paper
Etiology and susceptibility of urinary tract isolates in KosovaRAKA, Lul; MULLIQI-OSMANI, Gjyle; BERISHA, Lule et al.International journal of antimicrobial agents. 2004, Vol 23, pp S2-S5, issn 0924-8579, SUP1Conference Paper